Terms: = Gastric cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Treatment
47 results:
1. Germline Mutations of Holliday Junction Resolvase Genes in Multiple Primary Malignancies Involving Lung cancer Lead to PARP Inhibitor Sensitization.
Wang H; Chen Y; Wang X; Huang B; Xie J; Yin H; Yang J; Wu J; Yuan J; Zhang J
Clin Cancer Res; 2024 Apr; 30(8):1607-1618. PubMed ID: 38349998
[TBL] [Abstract] [Full Text] [Related]
2. Tumor-positive peritoneal cytology in patients with gastric cancer is associated with poor outcome: A nationwide study.
Van Der Sluis K; Taylor SN; Kodach LL; van Dieren JM; de Hingh IHJT; Wijnhoven BPL; Verhoeven RHA; Vollebergh MA; van Sandick JW
Eur J Cancer; 2024 Mar; 199():113541. PubMed ID: 38237371
[TBL] [Abstract] [Full Text] [Related]
3. Influence of Procedural Volume on the Outcome of gastric Endoscopic Submucosal Dissection: A Nationwide Population-Based Study Using Administrative Data.
Park JY; Kim MS; Kim BJ; Kim JG
Gastroenterology; 2024 Apr; 166(4):680-689.e4. PubMed ID: 38123025
[TBL] [Abstract] [Full Text] [Related]
4. Proteomic profiling of gastric cancer with peritoneal metastasis identifies a protein signature associated with immune microenvironment and patient outcome.
Chen Y; Cai G; Jiang J; He C; Chen Y; Ding Y; Lu J; Zhao W; Yang Y; Zhang Y; Wu G; Wang H; Zhou Z; Teng L
Gastric Cancer; 2023 Jul; 26(4):504-516. PubMed ID: 36930369
[TBL] [Abstract] [Full Text] [Related]
5. The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study.
Zhang C; Wu B; Yang H; Yao Z; Zhang N; Tan F; Liu M; Xu K; Chen L; Xing J; Cui M; Su X
BMC Cancer; 2022 Nov; 22(1):1223. PubMed ID: 36443694
[TBL] [Abstract] [Full Text] [Related]
6. The factors influencing the accuracy of pre-operative endoscopic ultrasonography assessment in endoscopic treatments for gastrointestinal tumors.
Zhao Y; Ren M; Jia A; Zhang J; Wang S; Zhao Q; Cai G; He S
Cancer Med; 2023 Feb; 12(4):4321-4331. PubMed ID: 36177606
[TBL] [Abstract] [Full Text] [Related]
7. Screening, characterization and anti-cancer application of purified intracellular MGL.
Sharma B; Devi S; Kumar R; Kanwar SS
Int J Biol Macromol; 2022 Sep; 217():96-110. PubMed ID: 35817235
[TBL] [Abstract] [Full Text] [Related]
8. Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma.
Margalit O; Yu S; Shacham-Shmueli E; Strauss G; Yang YX; Lawrence YR; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Mamtani R; Boursi B
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1703-1708. PubMed ID: 35066662
[TBL] [Abstract] [Full Text] [Related]
9. Radical D2 gastrectomy with adjuvant chemotherapy for stage IB/II/III distal gastric cancers in the era of perioperative chemotherapy: A propensity matched comparison.
Singh HK; Chaudhari V; Batra S; Ostwal V; Ramaswamy A; Mokal S; Shrikhande SV; Bhandare MS
Am J Surg; 2022 Jun; 223(6):1055-1062. PubMed ID: 34756584
[TBL] [Abstract] [Full Text] [Related]
10. Management and Survival Analysis of Gastrointestinal Neuroendocrine Tumors by Different Tumor Characteristics: Tertiary Center Experience.
Gonulal B; Bilgic Y; Akbulut S; Karabulut E; Samdanci ET
J Gastrointest Cancer; 2022 Dec; 53(4):915-920. PubMed ID: 34524616
[TBL] [Abstract] [Full Text] [Related]
11. [Comparison of long-term outcomes between endoscopic submucosal dissection and surgical resection for early gastric cancer with undifferentiated histology].
Zhang QR; Guo CG; Zhang YM; Xue LY; He S; Dou LZ; Liu Y; Shi L; Zhao DB; Wang GQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):413-419. PubMed ID: 34000770
[No Abstract] [Full Text] [Related]
12. Reversal Effect of Dihydromyricetin on Multiple Drug Resistance in SGC7901/5-FU Cells.
Wu M; Jiang M; Dong T; Xu L; Lv J; Xue M; Huang M
Asian Pac J Cancer Prev; 2020 May; 21(5):1269-1274. PubMed ID: 32458632
[TBL] [Abstract] [Full Text] [Related]
13. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy.
Fu J; Tang L; Li ZY; Li XT; Zhu HF; Sun YS; Ji JF
Eur J Radiol; 2020 Jul; 128():108974. PubMed ID: 32416553
[TBL] [Abstract] [Full Text] [Related]
14. Immune Checkpoint Inhibitors in Pre-Treated gastric cancer Patients: Results from a Literature-Based Meta-Analysis.
Roviello G; Corona SP; D'Angelo A; Rosellini P; Nobili S; Mini E
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936762
[TBL] [Abstract] [Full Text] [Related]
15. Association between time interval from neoadjuvant chemoradiotherapy to surgery and complete histological tumor response in esophageal and gastroesophageal junction cancer: a national cohort study.
Klevebro F; Nilsson K; Lindblad M; Ekman S; Johansson J; Lundell L; Ndegwa N; Hedberg J; Nilsson M
Dis Esophagus; 2020 May; 33(5):. PubMed ID: 31676895
[TBL] [Abstract] [Full Text] [Related]
16. Bariatric surgery, compared to medical treatment, reduces morbidity at all ages but does not reduce mortality in patients aged < 43 years, especially if diabetes mellitus is present: a post hoc analysis of two retrospective cohort studies.
Pontiroli AE; Ceriani V; Tagliabue E; Zakaria AS; Veronelli A; Folli F; Zanoni I
Acta Diabetol; 2020 Mar; 57(3):323-333. PubMed ID: 31598798
[TBL] [Abstract] [Full Text] [Related]
17. Long-term clinical outcomes of endoscopic vs. surgical resection for early gastric cancer with undifferentiated histology.
Lim JH; Kim J; Kim SG; Chung H
Surg Endosc; 2019 Nov; 33(11):3589-3599. PubMed ID: 30604260
[TBL] [Abstract] [Full Text] [Related]
18. The combination of apatinib and S-1 for the treatment of advanced gastric cancer in China: A meta-analysis of randomized controlled trials.
Liu Y; Zhou C; Zhang K; Feng Y; Zhang R
Medicine (Baltimore); 2018 Nov; 97(47):e13259. PubMed ID: 30461630
[TBL] [Abstract] [Full Text] [Related]
19. Incidence of Diabetes Mellitus, Cardiovascular Diseases, and cancer in Patients Undergoing Malabsorptive Surgery (Biliopancreatic Diversion and Biliointestinal Bypass) vs Medical treatment.
Pontiroli AE; Ceriani V; Sarro G; Micheletto G; Giovanelli A; Zakaria AS; Fanchini M; Osio C; Nosari I; Veronelli AM; Folli F;
Obes Surg; 2019 Mar; 29(3):935-942. PubMed ID: 30448983
[TBL] [Abstract] [Full Text] [Related]
20. Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study.
Elzarkaa AA; Shaalan W; Elemam D; Mansour H; Melis M; Malik E; Soliman AA
J Gynecol Oncol; 2018 Jul; 29(4):e47. PubMed ID: 29770618
[TBL] [Abstract] [Full Text] [Related]
[Next]
